Hangzhou Aorui Biotechnology

Developer of in vitro-diagnostic products for cancer early screening and early diagnosis

placeHangzhou, Zhejiang, China calendar_todayFounded 2018 language oriomics.com

Investor mix

2 investors on record; lead investors include Fortune Capital.

Investor typeCountShare
Venture capital2100%
Coming soon